- Home
- PULM vs CARM Comparison
PULM vs CARM Comparison
Compare PULM & CARM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PULM
- CARM
- Stock Information
- Founded
- PULM 2003
- CARM 2016
- Country
- PULM United States
- CARM United States
- Employees
- PULM N/A
- CARM N/A
- Industry
- PULM Biotechnology: Pharmaceutical Preparations
- CARM Biotechnology: Pharmaceutical Preparations
- Sector
- PULM Health Care
- CARM Health Care
- Exchange
- PULM Nasdaq
- CARM Nasdaq
- Market Cap
- PULM 21.0M
- CARM 19.7M
- IPO Year
- PULM N/A
- CARM N/A
- Fundamental
- Price
- PULM $8.92
- CARM $0.45
- Analyst Decision
- PULM
- CARM Hold
- Analyst Count
- PULM 0
- CARM 5
- Target Price
- PULM N/A
- CARM $4.57
- AVG Volume (30 Days)
- PULM 36.8K
- CARM 514.4K
- Earning Date
- PULM 03-27-2025
- CARM 03-31-2025
- Dividend Yield
- PULM N/A
- CARM N/A
- EPS Growth
- PULM N/A
- CARM N/A
- EPS
- PULM N/A
- CARM N/A
- Revenue
- PULM $10,005,000.00
- CARM $20,268,000.00
- Revenue This Year
- PULM N/A
- CARM $46.34
- Revenue Next Year
- PULM $1.00
- CARM N/A
- P/E Ratio
- PULM N/A
- CARM N/A
- Revenue Growth
- PULM 47.05
- CARM 41.13
- 52 Week Low
- PULM $1.55
- CARM $0.38
- 52 Week High
- PULM $10.40
- CARM $2.77
- Technical
- Relative Strength Index (RSI)
- PULM 62.72
- CARM 44.17
- Support Level
- PULM $8.80
- CARM $0.43
- Resistance Level
- PULM $10.40
- CARM $0.50
- Average True Range (ATR)
- PULM 0.59
- CARM 0.05
- MACD
- PULM 0.15
- CARM 0.00
- Stochastic Oscillator
- PULM 56.21
- CARM 28.16
About PULM Pulmatrix Inc.
Pulmatrix Inc is a clinical-stage biotechnology company. The company is focused on the discovery and development of novel inhaled therapeutic products intended to prevent and treat respiratory diseases and infections with significant unmet medical needs. Pulmatrix designs and develops inhaled therapeutic products based on its proprietary dry powder delivery technology, iSPERSE (inhaled Small Particles Easily Respirable and Emitted), which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. The iSPERSE powders are engineered to be small, dense particles with dispersibility and delivery to airways.
About CARM Carisma Therapeutics Inc.
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.